Peter Greenleaf, chair of the board overseeing the $84 million InvestMaryland venture fund, is taking a CEO job with Massachusetts-based biotech company Histogenics.
Greenleaf, former president of MedImmune in Gaithersburg, will remain chairman of the InvestMaryland board, a four-year position, at the request of Governor Martin O’Malley.
Read more here.
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!
Donate to the Journalism Fund
Your support powers our independent journalism. Unlike most business-media outlets, we don’t have a paywall. Instead, we count on your personal and organizational contributions.